Skip to main contentSkip to navigation
Sirius Investors
Demant A/S

Demant A/S

WILYY
OTCHealthcare

Demant A/S (WILYY) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Demant A/S's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2025
P/E Ratio
29.44
Moderate
WeakModerateStrong
P/B Ratio
4.62
Moderate
WeakModerateStrong
Earnings Yield
3.40%
Yield Trap
WeakModerateStrong

Profitability Health

2025
Return on Equity
15.70%
Strong
WeakModerateStrong
Operating Margin
17.61%
Moderate
WeakModerateStrong
Net Profit Margin
6.69%
Weak
WeakModerateStrong

Growth Indicators

2025
Revenue Growth
2.46%
Weak
WeakModerateStrong
Net Income Growth
-35.27%
Weak
WeakModerateStrong
EPS Growth
-35.50%
Weak
WeakModerateStrong

Efficiency & Liquidity

2025
Current Ratio
1.33
Moderate
WeakModerateStrong
Quick Ratio
0.98
Weak
WeakModerateStrong
Asset Turnover
0.59x
Moderate
WeakModerateStrong
Inventory Turnover
2.66x
Weak
WeakModerateStrong

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2025
Free Cash Flow Yield
7.26%
Strong
WeakModerateStrong
EV / Free Cash Flow
20.50x
Strong
WeakModerateStrong
Net Debt / EBITDA
4.33x
Weak
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.763
Weak
WeakModerateStrong
Return on Invested Capital
9.22%
Weak
WeakModerateStrong
Cash Conversion Cycle
162.61 days
Weak
WeakModerateStrong

Fortress screener guardrails

1/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for WILYY.

View Financial Statements